XML 34 R19.htm IDEA: XBRL DOCUMENT v3.20.2
Note L - Stock-based Compensation
12 Months Ended
Jun. 30, 2020
Notes to Financial Statements  
Share-based Payment Arrangement [Text Block]
L
. STOCK
-BASED COMPENSATION
 
In fiscal
2019,
the Company adopted the Twin Disc, Incorporated
2018
Long-Term Incentive Plan (the
“2018
LTI Plan”). Benefits under the
2018
LTI Plan
may
be granted, awarded or paid in any
one
or a combination of stock options, stock appreciation rights, restricted stock awards, restricted stock units, cash-settled restricted stock units, performance stock awards, performance stock unit awards, performance unit awards, and dividend equivalent awards. There is reserved for issuance under the Plan an aggregate of
850,000
shares of the Company's common stock, which
may
be authorized and unissued shares or shares reacquired by the Company in the open market or a combination of both. The aggregate amount is subject to proportionate adjustments for stock dividends, stock splits and similar changes.
 
In fiscal
2011,
the Company adopted the Twin Disc, Incorporated
2010
Stock Incentive Plan for Non-Employee Directors (the
“2010
Directors' Plan”), a plan to grant non-employee directors equity-based awards up to
250,000
shares of common stock, and the Twin Disc, Incorporated
2010
Long-Term Incentive Compensation Plan (the
“2010
Employee Incentive Plan”), a plan under which officers and key employees
may
be granted equity-based awards up to
650,000
shares of common stock. Equity-based awards granted under these plans include performance shares and restricted stock.
 
Shares available for future awards as of
June 30
were as follows:
 
       
2020
   
2019
 
2018 LTI Plan
   
492,591
     
742,325
 
2010 Directors' Plan
   
12,865
     
61,354
 
 
Performance Stock Awards (“PSA”)
 
In fiscal
2020
and
2019,
the Company granted a target number of
131,688
and
50,004
PSAs, respectively, to various employees of the Company, including executive officers.
 
The PSAs granted in fiscal
2020
will vest if the Company achieves performance-based target objectives relating to average return on invested capital, average annual sales and average annual Earnings Per Share (“EPS”) (as defined in the PSA Grant Agreement), in the cumulative
three
fiscal year period ending
June 30, 2022.
These PSAs are subject to adjustment if the Company's return on invested capital, net sales, and EPS for the period falls below or exceeds the specified target objective, and the maximum number of performance shares that can be awarded if the target objective is exceeded is
184,766.
Based upon actual results to date, the Company is
not
currently accruing compensation expense for these PSAs.
 
The PSAs granted in fiscal
2019
will vest if the Company achieves performance-based target objectives relating to average return on invested capital, average annual sales and average annual Earnings Per Share (“EPS”) (as defined in the PSA Grant Agreement), in the cumulative
three
fiscal year period ending
June 30, 2021.
These PSAs are subject to adjustment if the Company's return on invested capital, net sales, and EPS for the period falls below or exceeds the specified target objective, and the maximum number of performance shares that can be awarded if the target objective is exceeded is
67,007.
Based upon actual results to date, the Company is
not
currently accruing compensation expense for these PSAs.
 
There were
167,848
and
96,124
unvested PSAs outstanding at
June 30, 2020
and
2019,
respectively. A total of
13,844
and
0
shares of performance stock awards were forfeited during fiscal
2020
and
2019,
respectively. The fair value of the PSAs (on the date of grant) is expensed over the performance period for the shares that are expected to ultimately vest. The compensation (benefit) expense for the year ended
June 30, 2020
and
2019,
related PSAs, was (
$368
) and
$1,196,
respectively. The tax (expense) benefit from compensation (benefit) expense for the year ended
June 30, 2020
and
2019,
related PSAs, was (
$87
) and
$278,
respectively. The weighted average grant date fair value of the unvested awards at
June 30, 2020
was
$14.78.
At
June 30, 2020,
the Company had
$2,480
of unrecognized compensation expense related to the unvested shares that would vest if the specified target objective was achieved for the fiscal
2020
and
2019
awards. The total fair value of performance stock awards vested in fiscal
2020
was
$167.
The total fair value of performance stock awards vested in fiscal
2019
was
$1,228.
 
Restricted Stock Awards (“RS”)
 
The Company has unvested RS outstanding that will vest if certain service conditions are fulfilled. The fair value of the RS grants is recorded as compensation over the vesting period, which is generally
1
to
3
years. During fiscal
2020
and
2019,
the Company granted
180,379
and
43,305
service based restricted shares, respectively, to employees and non-employee directors in each year. A total of
20,511
and
3,784
shares of restricted stock were forfeited during fiscal
2020
and
2019,
respectively. There were
231,379
and
172,637
unvested shares outstanding at
June 30, 2020
and
2019,
respectively. Compensation expense of
$1,200
and
$1,096
was recognized during the year ended
June 30, 2020
and
2019,
respectively, related to these service-based awards. The tax benefit from compensation expense for the year ended
June 30, 2020
and
2019
related to these service-based awards, was
$283
and
$255,
respectively. The total fair value of restricted stock grants vested in fiscal
2020
and
2019
was
$1,241
and
$2,391,
respectively. As of
June 30, 2020,
the Company had
$1,307
of unrecognized compensation expense related to restricted stock which will be recognized over the next
three
years.
 
Restricted Stock
Unit
Awards (“RS
U
”)
 
Under the
2018
Long Term Incentive Plan, the Company has been authorized to issue RSUs. The RSUs entitle the employee to shares of common stock of the Company if the employee remains employed by the Company through a specified date, generally
three
years from the date of grant. During fiscal
2019,
the Company granted
37,950
RSUs to various employees of the Company, including executive officers. The fair value of the RSUs (on the date of grant) is recorded as compensation expense over the vesting period. There were
37,950
unvested RSUs outstanding at
June 30, 2020
and
June 30, 2019.
Compensation expense of
$326
and
$299
was recognized during the year ended
June 30, 2020
and
2019,
respectively. The tax benefit from compensation expense for the year ended
June 30, 2020
and
2019,
related to these service-based awards, was
$77
and
$69,
respectively. The weighted average grant date fair value of the unvested awards at
June 30, 2020
was
$25.77.
As of
June 30, 2020,
the Company had
$353
of unrecognized compensation expense related to RSUs which will be recognized over the next
two
years.
 
Stock Options
 
The
2010
Directors' Plan
may
grant options to purchase shares of common stock, at the discretion of the Board of Directors, to non-employee directors who are elected or reelected to the board, or who continue to serve on the board. Such options carry an exercise price equal to the fair market value of the Company's common stock as of the date of grant, vest immediately, and expire
ten
years after the date of grant. Options granted under the
2018
Employee Incentive Plan are determined to be non-qualified or incentive stock options as of the date of grant, and
may
carry a vesting schedule. For options under the
2018
Employee Incentive Plan that are intended to qualify as incentive stock options, if the optionee owns more than
10%
of the total combined voting power of the Company's stock, the price will
not
be less than
110%
of the grant date fair market value and the options expire
five
years after the date of grant. There were
no
incentive options granted to a greater than
10%
shareholder during the years presented. There were
no
options outstanding under the
2010
Directors' Plan and the
2018
Employee Incentive Plan as of
June 30, 2020
and
2019.